BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$70.24
0.55 (0.79%)
▲
5d:
+5.99%
30d:
+5.72%
90d:
-3.22%
BUY
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.5/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 15.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 15.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $70.24, which is considered extended relative to its 30-day fair value range of $65.95 to $69.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 133.2) compared to its historical average (217.3). Remarkably, the market is currently pricing in an annual earnings decline of 15.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $65.59, while resistance sits at $72.54.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+45.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $65.59, while resistance sits at $72.54.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+45.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$65.95 -
$69.01
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.6% below Wall St target ($102.28)
Trading Range Analysis
30-Day Trading Range
$65.95 -
$69.01
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$65.59
Resistance Level
$72.54
Current Trend
Strong Uptrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
133.21
Wall Street Target
$102.28
(+45.6%)
Revenue Growth (YoY)
66.8%
Profit Margin
-124.4%
Valuation Discount vs History
-15.1% cheaper
PE vs Historical
133.2 vs 217.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.1%
(market-implied from PE analysis)
1-Year Target
$63.22
(-10%)
2-Year Target
$56.89
(-19%)
3-Year Target
$51.20
(-27%)
3-Yr Target (if PE normalizes)
(PE: 133→217)
$83.53
(+19%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 133.2 to 217.3
Stabilization Target:
$114.58
(+63.1%)
PE Expansion Potential:
+63.1%
Share & Embed Analysis
Last updated: June 27, 2026 5:15 AM ET
Data refreshes hourly during market hours. Next update: 6:15 AM
Data refreshes hourly during market hours. Next update: 6:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 65 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 67 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 57 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
